enow.com Web Search

  1. Ads

    related to: long acting insulin pen names list printable

Search results

  1. Results from the WOW.Com Content Network
  2. Insulin (medication) - Wikipedia

    en.wikipedia.org/wiki/Insulin_(medication)

    The long acting insulin is given once (usually glargine, Lantus) or twice (usually detemir, Levemir) daily to provide a base, or basal insulin level. Rapid acting (RA) insulin is given before meals and snacks. A similar profile can be provided using an insulin pump where rapid acting insulin is given as the basal and premeal bolus insulin.

  3. Insulin glargine - Wikipedia

    en.wikipedia.org/wiki/Insulin_glargine

    Insulin glargine sold under the brand name Lantus among others is a long-acting modified form of medical insulin, used in the management of type 1 and type 2 diabetes. [7] It is injected just under the skin . [ 7 ]

  4. Lixisenatide - Wikipedia

    en.wikipedia.org/wiki/Lixisenatide

    [20] [21] In May 2016 by a vote of 12–2, with several members of the committee expressing reservations about Sanofi's plans to offer two pens with different ratios of insulin glargine and lixisenatide - one for people who had never taken insulin before and one for people who had; there was also concern about how to handle dosing when ...

  5. Insulin icodec - Wikipedia

    en.wikipedia.org/wiki/Insulin_icodec

    It is an ultralong-acting basal insulin analogue that is developed by Novo Nordisk. [3] It has a plasma half-life more than eight days [6] (compared to 25 hours of the previous longest-acting insulin analogue insulin degludec), making it a once-weekly basal insulin. [6] Like insulin, icodec is composed of two peptide chains linked by a ...

  6. Insulin degludec - Wikipedia

    en.wikipedia.org/wiki/Insulin_degludec

    Insulin degludec is an ultra-long acting insulin that, unlike insulin glargine, is active at a physiologic pH. The addition of hexadecanedioic acid via an amide linkage to lysine at the B29 position allows for the formation of multi-hexamers in subcutaneous tissues. [ 16 ]

  7. Novo Nordisk to discontinue Levemir insulin in U.S. market - AOL

    www.aol.com/news/novo-nordisk-discontinue...

    Novo has another long-acting insulin, Tresiba, on the market. "Novo Nordisk will phase out, then permanently discontinue Levemir in the U.S. on December 31, 2024," the company said in a statement.

  1. Ads

    related to: long acting insulin pen names list printable